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This paper provides a brief outline of the regulation of 
biotechnology across the board in the United States to­
day. An important feature of this discussion is that its 
focus is not on laws and regulations for the issues of 
biotechnology, but rather on science.
It is no surprise to those who work in this legislative 
area that regulation is not driven by legislators, law­
yers and regulators, but that it is driven by the science 
that underlies the regulation. The history of govern­
ment regulation of the food supply is the history of sci­
ence, not the history of the laws and regulations that 
have been involved.
This is illustrated by the following example from a 
statute enacted by the English Parliament in 1263. Par­
liament decreed, in order to protect the safety of the 
food supply, that nothing could be added to the then 
staple foods in England that was “not wholesome for 
man’s body”. The statutory standard today is remark­
ably similar, stating that nothing can be added to foods 
if it is a “poisonous or deleterious substance that may 
render the food injurious to health”. And I challenge 
anyone to point out the difference between “not 
wholesome for man’s body” which was the statutory 
standard 700 years ago, and “poisonous or deleterious 
substance which may render the food injurious to 
health”, which is our statutory standard today and has 
been since the English statute of 1860. There is no dif­
ference.
If the 1263 law was the only law of the land today, 
the Food and Drug Administration (FDA) and United 
States Department of Agriculture (USDA) would be
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doing nothing differently. Thus the issue is clearly an 
issue of science, not of laws and regulation. 
Government regulation of food and drugs, (which 
have always been related), has been of concern in our 
country for its entire 200 year history. Our earliest 
governmental federal statutes regulating any form of 
business were directed at the drug supply. From the 
Vaccine Act of 1813 on through the latter part of that century there was a 
plethora of laws and regulations enacted to prevent importation and ex­
portation of adulterated food of any kind. These laws and regulations did 
not deal with regulation of domestic commerce of food and drugs because 
of a concern that these were matters for state and local governments only. 
In the last quarter of the 1800s in the United States we had a constitu­
tional debate in Congress, in particular, over the role of the Federal Govern­
ment which at that time was thought to be restricted to foreign commerce. 
Domestic commerce was considered a matter solely for state, local and 
county governments.
It was only the first decade of this century that Congress’ and the Su­
preme Court’s view changed. At that time, the laws that are seen today 
were put in place. Between 1900 and 1910, there was the Vaccine Act of 
1902, the Food and Drugs Act of 1906, the Federal Meat Inspection Acts of 
1906 and 1907, and the Insecticides Act of 1910. These laws effected what 
we still regard, with years and decades of enactment and revision, as our 
basic food protection laws. In the 1970s a plethora of amendments and re­
visions and new environmental statues were added. In addition to these 
regulatory laws, an overlay of broad statutory authority exists, vested in 
the United States Government, which regulates indirectly.
For example, the National Institutes of Health (NIH), the Department 
of Defense and other government agencies have broadly contracted grant 
authority, and that authority can be used to impose any form of restriction 
believed reasonable. That was the origin of the recombinant DNA guide­
lines created in the 1970s at NIH.
Many basic research scientists in the debate that occurred in the mid- 
1970s were shocked to discover that they could be regulated. The theory 
was promoted in conferences such as this from 1976 to 1978, by scientist 
upon scientist who took the lectern and said, “We demand the right to free­
dom of speech!”, to which I always responded “Everybody in this country 
has the right to freedom of speech, but you do not have the right to free-
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search was free to do so without restrictions. But once in action, the basic 
bench scientist stands in no different a position than the railroad or the 
pharmaceutical industry, or the food industry or anybody else. Scientists 
are as subject to regulation in our country as any other form of commercial 
enterprise. I cannot tell you how disappointed the research scientists were 
to hear that news.
Regulatory statutes can often be divided into two basic kinds of stat­
utes—those that deal with products, like foods and drugs, and those that 
deal with processes, usually industrial processes, like clean air and clean 
water.
For the purposes of looking at how recombinant DNA and biotechnol­
ogy can be regulated, it is presented as a progression from the laboratory to 
the consumer. This progression begins with basic chemicals. Is there any 
regulation of basic chemicals in our country? Absolutely; starting with the 
Toxic Substances Control Act, enacted in 1976 precisely to fill the gaps of 
all the other regulatory controls enacted over the years and to make sure 
that there was no lack of regulation. Before a new chemical of any kind 
may be put to any use in this country, it must survive a pre-market notifi­
cation submitted to the Environmental Protection Agency (EPA), and it 
must not be vetoed for marketing. The Environmental Protection Agency 
has the identical authority over all new chemicals that the FDA had over 
all new drugs between 1938 and 1962. Not pre-market approval, but pre­
market notification and veto—a slightly different form of regulation, but 
one which is effective nonetheless. And very stringently used by EPA these 
days. Therefore, basic chemicals are fully subject to regulation by the 
United States Government.
Next, an examination of plants and animals. Just plants as they sit there 
in the field, and animals as they walk around. Suppose we start tinkering 
with them, as we all know we are. Are they regulated? There are actually 
more regulations and more regulatory laws authorizing USDA in particular 
to regulate plants and animals as such than there are anything else in this 
entire system.
1 will name some of these. The Organic Act allows USDA to prevent 
plant pests; the Plant Pest Act, the Plant Quarantine Act, the Noxious
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Weed Act, the Federal Seed Act, Animal Quarantine 
laws, the meat and poultry, egg and food laws, the En­
dangered Species Act, and then the Department of the 
Interior has the authority to restrict the import and 
introduction of exotic plants or animals into the 
natural ecosystem. There are enough laws here. In 
fact, we have more than enough laws. It makes sense to take all of these 
crazy statutes and try to put them all together and make sense out of 
them. Something that Congress has never considered, and in its current 
state of affairs, probably will not get around to.
It is silly to think that entire new plant systems or animals could be in­
jected into our environment without government control. Having at one 
point served on an Office of Technology Assessment (OTA) Committee 
looking precisely at the issue of whether there were regulatory gaps in this 
area, we could find none.
The introduction of plants and animals into consumer products—do we 
have authority there for the government to control the issue? We have the 
FDA, of course, and its control over food safety, that I will come back to in 
a moment; EPA continues to control pesticides; the Consumer Product 
Safety Commission was authorized in 1972 to control all consumer prod­
ucts not otherwise regulated by USDA or FDA; and we have USDA author­
ity with continuous inspection over meat, poultry, and eggs. The odds of 
anything slipping through that system are very small indeed.
Let us go on to the workplace, where these products are produced. The 
Occupational Safety and Health Administration (OSHA) was created in 
1970 precisely to deal with all workplace effects. In 1985, OSHA an­
nounced that its controls applied to all use of biotechnology in any work­
place whatever including the research laboratories.
Let us look then at the environmental effects. Effects in the air, the wa­
ter, the so-called, one of the great misnomers of all time—“deliberate re­
lease” problem. The Environmental Protection Agency has plenary author­
ity under Clean Air Act, Clean Water Act, Resource Conservation and Re­
covery Act (RCRA), Superfund, the Marine Protection Act and a variety of 
statutes and regulations that we need not get into. The environment is as 
clouded with regulatory control as is the food and drug supply.
Transportation—is there any way that these rambunctious recombi­
nant DNA molecules can be transported around the country under unsafe 
conditions? Well, the post office itself has already issued regulations saying
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you cannot mail them. The Center for Disease Con­
trol (CDC) has control over all etiologic agents of any 
kind; nobody can deal with them without CDC ap­
proval. The Department of Transportation deals with 
them under the Hazardous Materials Transport Act. 
So we have more than enough authority there.
Now you might say that pretty much covers everything. But additional 
regulatory controls in the United States make sure there are no cracks in 
this entire regulatory edifice. To make certain that everything else is con­
trolled, Section 301 of the Public Health Service Act in effect authorizes 
the Public Health Service to do anything they need to do to protect the 
public health. Section 361, which I actually authored in the debates in 
1976, is the single regulatory control mechanism for all of the new biotech­
nology. It states that the public health service, including FDA, may take 
any action of any kind whatever, intra-state or inter-state, in order to pre­
vent (not control) the spread of communicable disease of any form. It is a 
holdover from 100 years ago, in the days when we were terribly concerned 
about the spread of infectious disease. That statute, one sentence long, 
could be used to control all aspects of biotechnology.
Thus we have a regulatory scheme in place in the United States today 
that is more than sufficient to control biotechnology. The real problem is 
enormous overlap of among these statutes. There is virtually nothing that 
cannot be controlled. I will get to two issues that have been raised about 
that. My judgement is there is no gap here, only the real problem of admin­
istrative overlap and therefore the need for administrative comity. I always 
pronounce that very carefully; we have enough administrative comedy.
The problem is one of coordination, making certain that we do not kill an 
industry, kill a research, kill the greatest opportunity for humankind to im­
prove public health that the world has ever seen.
There have been many people who have suggested that on top of all of 
this, we need new statutes and regulations to deal with biotechnology per 
se. I find that ludicrous. The attempt by the United States Senate in par­
ticular in 1978, to enact legislation designed to deal precisely with a broad 
new overarching control of biotechnology in my judgement would have 
nipped the scientific promise of biotechnology before it could have begun. 
That was successfully avoided by scientists uniting in their opposition; by 
discussions in particular with Senator Edward Kennedy, scientific progress 
and the need for flexibility; and by taking upon themselves in one of the
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most extraordinary and wonderful events 1 have ever seen in the field of 
science, self-regulation through basically a voluntary regulatory system 
set up by the NIH in the form of the recombinant DNA guidelines; the de­
velopment of the Recombinant Advisory Committee (RAC). If science had 
not acted responsibly, and had not done that, we would have seen the Sen­
ate enact legislation and we would not have the progress that we have seen 
to date.
The two issues mentioned as needing additional controls are: worker 
surveillance, (as though OSHA did not exist and did not have its author­
ity), and “deliberate release”, (to return to what I regarded as one of the 
great misnomers of all time). I keep pointing out the whole purpose of 
biotechnology is to release something into the environment, otherwise if 
you contained it, it would not very useful. Nonetheless, that has become 
one of the issues in terms of adequate regulation.
Our OTA committee reviewed the issues in detail and concluded that 
once again, we have more than enough laws. If we needed to energize some 
of our regulatory agencies to utilize those statutes, to take the opportunity 
to increase regulation in particular areas where it was needed, that was 
fine. But we did not need new laws and regulations.
Now let me turn very briefly to FDA and the regulation of food in par­
ticular. No new food ingredient—whether we call it a whole food or a food 
substance (we are not going to call it a food additive because that prejudges 
the issue), may be used in the food supply in the United States whether in 
meat or poultry or any other food unless it satisfies one of three criter­
ia: 1) it must have been approved by USDA or FDA between 1938 and
1958, (i.e., a prior sanctioned substance); or 2) it must be “generally recog­
nized as safe”, a GRAS substance; or 3) it must be the subject of a food ad­
ditive regulation. If it is not one of those three, it is illegal.
It is very simple. We have a wonderfully easy system, when you get 
right down to it. All you have to do is understand those three concepts. 
Now obviously there were no recombinant products prior to the Food Ad­
ditives Amendment of 1958, and so one might easily conclude that ends at 
all. New biotechnology has to be regulated through a food additive regula­
tion. Not true.
When one takes a plant and alters it, one can do that by natural breed­
ing or selection or one can do it by recombinant DNA. When FDA issued its 
regulations well before biotechnology in the early 1970s, the agency antici­
pated the kinds of issues from breeding and selection and said that it is a
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matter of judgement—a matter of science, not of laws and regulations—as 
to when a food ingredient is so changed that it is no longer subject to a 
prior sanction or a GRAS determination and requires a food additive regu­
lation. Or when it changes just slightly, but not enough to worry about, it 
can remain subject to that prior sanction, or subject to an existing GRAS 
determination, or indeed subject to an existing food additive regulation, 
and does not need a new regulation.
Now FDA issued those regulations before Paul Berg did his work and the 
Recombinant Advisory Committee was formed. The regulations have not 
changed and they do not need to be changed. Some have argued that FDA 
should be more explicit; they should lay down heavy, rigid rules, telling ev­
erybody when things have changed so much that you need a new regula­
tion and when they are sufficiently similar that you do not need a new 
regulation. I think that would be foolhardy. I think we would have rules 
and regulations that would tie us in knots rather than being helpful. Flex­
ibility is a far greater attribute in government regulation than rigidity. It is, 
I hope, as meaningful to all of you as it has been to me, that the first FDA 
approval of a recombinant product came not in the form of a new, rigid, 
regulation, but in the form of a GRAS determination, thus sending a signal 
that FDA is prepared to remain flexible in its regulation in the future.
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